analyst

NASDAQ · MGNX
MacroGenics, Inc.
Healthcare · Biotechnology
$3.64
Down-$0.13 (-3.45%)
Updated Oct 7, 2026, 10:40 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 89.51M
- P/E ratio
- -1.18
- Dividend yield
- 0.00%
- 52-week range
- $1.29 – $5.08
- Volume
- 633.29K
- Avg. volume
- 946.23K
Price performance · MGNX
MGNX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
MGNX closed at $3.64 after 21 trading sessions, down 15.74% for the selected period.
- Last close
- $3.64
- Period change
- -15.74%
- Period low
- $3.58
- Period high
- $4.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $3.79 | $3.79 | $3.55 | $3.64 | 633.29K |
| Oct 5, 2026 | $3.65 | $3.855 | $3.495 | $3.77 | 605.94K |
| Oct 2, 2026 | $3.64 | $3.65 | $3.525 | $3.58 | 980.53K |
| Oct 1, 2026 | $3.85 | $3.88 | $3.585 | $3.60 | 656.63K |
| Sep 30, 2026 | $3.76 | $3.91 | $3.73 | $3.86 | 634.06K |
| Sep 29, 2026 | $4.08 | $4.09 | $3.75 | $3.77 | 616.43K |
| Sep 28, 2026 | $3.73 | $4.11 | $3.69 | $4.06 | 1.91M |
| Sep 25, 2026 | $3.79 | $3.86 | $3.72 | $3.74 | 604.62K |
| Sep 24, 2026 | $3.80 | $3.87 | $3.62 | $3.80 | 571.45K |
| Sep 23, 2026 | $4.12 | $4.12 | $3.78 | $3.80 | 524.59K |
| Sep 22, 2026 | $4.17 | $4.20 | $4.075 | $4.12 | 377.36K |
| Sep 21, 2026 | $4.16 | $4.185 | $4.08 | $4.12 | 310.5K |
| Sep 18, 2026 | $4.12 | $4.165 | $4.09 | $4.14 | 873.94K |
| Sep 17, 2026 | $4.15 | $4.18 | $4.03 | $4.13 | 438K |
| Sep 16, 2026 | $4.05 | $4.10 | $3.98 | $4.08 | 315.68K |
| Sep 15, 2026 | $4.19 | $4.19 | $3.99 | $4.04 | 264.98K |
| Sep 14, 2026 | $4.00 | $4.215 | $3.99 | $4.20 | 431.47K |
| Sep 11, 2026 | $4.02 | $4.09 | $3.91 | $4.00 | 381.93K |
| Sep 10, 2026 | $4.08 | $4.115 | $3.90 | $3.97 | 434.78K |
| Sep 9, 2026 | $4.29 | $4.2953 | $4.03 | $4.11 | 599.23K |
| Sep 8, 2026 | $4.29 | $4.43 | $4.11 | $4.32 | 419.59K |
Latest MGNX news
The latest Smart Investors Daily articles mentioning MGNX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

